ABERRANT β-CATENIN AND LEF1 EXPRESSION MAY PREDICT THE CLINICAL OUTCOME FOR PATIENTS WITH OROPHARYNGEAL CANCER.
| Autor: | PAPAGERAKIS, P., PANNONE, G., SHABANA, A-H., DEPONDT, J., SANTORO, A., GHIRTIS, K., BERDAL, A., PAPAGERAKIS, S. |
|---|---|
| Zdroj: | International Journal of Immunopathology & Pharmacology; Jan-Mar2012, Vol. 25 Issue 1, p135-146, 12p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|